Chimerix Inc. (NASDAQ:CMRX) shares, rose in value on Friday, 05/13/22, with the stock price up by 3.41% to the previous day’s close as strong demand from buyers drove the stock to $4.24.
Actively observing the price movement in the last trading, the stock closed the session at $4.10, falling within a range of $4.07 and $4.315. The value of beta (5-year monthly) was 1.34. Referring to stock’s 52-week performance, its high was $9.29, and the low was $3.34. On the whole, CMRX has fluctuated by -9.59% over the past month.
With the market capitalization of Chimerix Inc. currently standing at about $386.14 million, investors are eagerly awaiting this quarter’s results, scheduled for May 16, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.33, which is expected to increase to $0.71 for fiscal year -$0.16 and then to about -$0.19 by fiscal year 2023. Data indicates that the EPS growth is expected to be 92.20% in 2023, while the next year’s EPS growth is forecast to be -18.80%.
Wall Street analysts also predicted that in 2023, the company’s y-o-y revenues would reach $83.68 million, representing an increase of 4,128.40% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that CMRX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CMRX currently trading nearly -7.91% and -13.62% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.52, while the 7-day volatility ratio is showing 11.28% which for the 30-day chart, stands at 8.14%. Furthermore, Chimerix Inc. (CMRX)’s beta value is 1.29, and its average true range (ATR) is 0.39.
A comparison of Chimerix Inc. (CMRX) with its peers suggests the former has fared considerably weaker in the market. CMRX showed an intraday change of 3.41% in last session, and over the past year, it shrunk by -48.29%%. In comparison, SIGA Technologies Inc. (SIGA) has moved higher at 0.54% on the day and was up 6.12% over the past 12 months. On the other hand, the price of Johnson & Johnson (JNJ) has fallen -0.57% on the day. The stock, however, is off 3.89% from where it was a year ago. Additionally, there is a loss of -1.17% for Emergent BioSolutions Inc. (EBS) in last trading while the stock has seen an overall depriciation of -53.65%% over the past year. Other than that, the overall performance of the S&P 500 during the last trading session shows that it gained 2.39%. Meanwhile, the Dow Jones Industrial Improved by 1.47%.
Data on historical trading for Chimerix Inc. (NASDAQ:CMRX) indicates that the trading volumes over the past 3 months, they’ve averaged 1.16 million. According to company’s latest data on outstanding shares, there are 86.89 million shares outstanding.
Nearly 0.30% of Chimerix Inc.’s shares belong to company insiders and institutional investors own 59.40% of the company’s shares. The stock has fallen by -34.06% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CMRX stock heading into the next quarter.